Q BioMed Inc. Provides Important Update on Mannin Research Tie2 Technology Platform Development

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotechnology acceleration development company, provides the following update on its exclusively licensed platform technology asset from Mannin Research...

PharmaMar Announces Participation at the 17th Needham & Co Annual Healthcare Conference in New York City

PharmaMar (MCE: PHM), today announced it will be featured as a presenting company at the 17th Needham & Co Annual Healthcare Conference. The conference is being held on March 27-28 at the Westin...